Chengdu Zenitar Biomedical Technology Co., Ltd

This early-phase trial tested a new drug called flonoltinib maleate in 31 people with myeloproliferative neoplasms (MPNs), a group of bone marrow cancers. The main goals were to check safety, find the right dose, and see how the body processes the drug. Researchers hope this drug…

This early-phase trial tested a new drug called Purinostat Mesylate in 29 people with relapsed or refractory B-cell lymphomas, a type of blood cancer. The main goals were to check safety, find the right dose, and see how the drug moves through the body. Researchers hope this drug…

This early-stage study tested a new experimental drug, ZL-82, in 41 healthy adults to see if it is safe and how the body processes it. The drug targets a protein involved in immune signaling. Researchers also checked whether ZL-82 affects the heart's electrical activity. The resu…

This completed Phase 1 trial studied how taking flonoltinib maleate tablets with or without food changes the drug's levels in the blood. Twenty-four healthy adults aged 18 to 45 took a single 100 mg dose under both fed and fasting conditions. The goal was to understand food's imp…

This early-phase trial tested the safety and how the body processes flonoltinib maleate tablets in 40 healthy adults in China. Participants received a single oral dose of the drug or a placebo, with doses increasing across groups. The study focused on side effects and drug levels…